Recent advances in the diagnosis and management of amoebiasis
With increasing international travel and migration, tropical and infectious diseases once largely confined to specialist institutes now present more widely. Amoebiasis is a potentially dangerous example since it may closely mimic the presentation of inflammatory bowel disease. Misdiagnosis and treatment with immunosuppressants can result in fulminant amoebiasis and death. This review considers the epidemiology, pathogenesis, clinical features, diagnosis and treatment of intestinal and extraintestinal amoebiasis. It is written primarily for gastroenterologists, surgeons and acute physicians.
Authors
- Peter L. Chiodini (ORCID: https://orcid.org/0000-0003-0317-7090)
- Spyros I. Siakavellas (ORCID: https://orcid.org/0000-0001-8217-8950)
- Gauri Godbole
- Joseph Cooney (ORCID: https://orcid.org/0000-0002-9295-1625)
- Philip J Smith (ORCID: https://orcid.org/0000-0003-1568-3978)
- Richard Pollok (ORCID: https://orcid.org/0000-0001-6452-6763)
- Ula Mahadeva (ORCID: https://orcid.org/0000-0002-9459-3403)
Institutions
- University of Liverpool (GB)
- St George's, University of London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- St George’s University Hospitals NHS Foundation Trust (GB)
- Royal Liverpool University Hospital (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Hospital for Tropical Diseases (GB)
- Hippocration General Hospital (GR)
- UK Health Security Agency (GB)
Publication Details
- Journal
- Frontline Gastroenterology
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1136/flgastro-2023-102554
- Citations
- 5
- Primary Topic
- Amoebic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.95